glp 1 and parkinson's Neuroprotective Actions of Glucagon-Like Peptide-1 (GLP-1) Analogues in Alzheimer's Diseases | CNS Drugs Role of glucagon-like peptide-1 receptor

Phase I clinical trial results for Amgens experimental weight-loss drug, MariTide, indicate it may provide longer-lasting effects compared to existing glucagon-like peptide-1 (GLP-1) treatments such as Novo Nordisks Wegovy and EliLillys Zepbound.

Telehealth company Hims & Hers dropped its plan to offer a knockoff version of the weight-loss pill Wegovy two days after it announced the new drug and one day after the Food and Drug Administration threatened to restrict access to t

DPP-4 inhibitors block DPP-4 which in turn leaves GLP-1 active

An RD explains.

Explore how GLP-1 therapies are changing weight management and when to consult an obesity doctor.

Learn about private prescription prices, payment options, NHS eligibility, and practical strategies to reduce costs whilst maintaining safe, effective treatment for diabetes and weight management.